Right ventricular expression of NT‐proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension

Abstract Aims The Registry to Evaluate Early and Long‐Term PAH Disease Management (REVEAL) risk scores differentiate survivals in patients with pulmonary arterial hypertension (PAH). However, measurements of N‐terminal pro B‐type natriuretic peptide (NT‐proBNP) in the peripheral blood may not adequa...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wei‐Ting Chang, Jhih‐Yuan Shih, Chon‐Seng Hong, Yu‐Wen Lin, Yi‐Chen Chen, Chung‐Han Ho, Zhih‐Cherng Chen, Jun‐Neng Roan, Chih‐Hsin Hsu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Oxford University Press 2021-08-01
coleção:	ESC Heart Failure
Assuntos:	NT‐proBNP RV expression HF hospitalization Group I PAH
Acesso em linha:	https://doi.org/10.1002/ehf2.13410
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!